InvestorsHub Logo
Followers 40
Posts 1456
Boards Moderated 0
Alias Born 09/23/2013

Re: NYC Trader post# 1212837

Monday, 09/30/2013 10:44:36 AM

Monday, September 30, 2013 10:44:36 AM

Post# of 2341352
$NVLX By comparison, two independent Phase II clinical trials revealed that Nuvilex's pancreatic cancer treatment, namely the combination of tiny capsules containing live drug-activating cells together with the single cancer drug ifosfamide (used for many years to treat a variety of cancers), helped patients to a far better outcome than that previously reported with standard single-drug gemcitabine and even that reported for the just approved ABRAXANE-gemcitabine combination.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.